| 3/4/2024 | 300215000000 | DURVALUMAB 50MG/ML 2.4ML IS FOR CLINICAL RESEARCH PURPOSES (NOT IN THE SCOPE OF 2024/16 -19 NOTIFICATION.)+ | 9 | UNIT | 16887 | N/A | ŞULE MENE SAĞLIK ARAŞTIRMA EĞİTİM DANIŞMANLIK BİLİŞİM SANAYİ TİCARET ANONİM ŞİRKETİ |
| 3/4/2018 | 300490000000 | EYE DROPS (MP ARTELAC COMPLETE SDU 30 TR) (2019/5-ANNEX: 5 AND ANNEX2 NOT IN SCOPE OF NOTIFICATION.) (ESYA MEDICAL DEVICE DIRECTOR CAP.OLUP 2019/20 ANNEX 1-A TEB. IS NOT COVERED.
| 9696 | Units | 22141.66 | N/A | BAUSCH & LOMB SAGLIKVE OPTIK ÜRÜNLERI TIC.A.S. |
| 3/21/2018 | 300290100000 | HUMAN BLOOD USED IN THE INDUSTRY LABORATORIES FOR ANALYSIS AND RESEARCH (NOT IN THE SCOPE OF 2019/5 NOTIFICATION.)
| 10 | Units | 2868.79 | N/A | DIAPRO TIBBI ÜRÜNLERSANAYI VE TICARET A.S. |
| 3/4/2018 | 300490000000 | EYE DROPS (ARTELAC ADVANCED SDU 30'S) (2019/5-ANNEX: 5 AND ANNEX2 NOT IN SCOPE OF THE NOTIFICATION.) (ESYA MEDICAL DEVICE DIRECT. KAP.OLUP 2019/20 ANNEX 1-A TEB. IS NOT COVERED.
| 32094 | Units | 66904.48 | N/A | BAUSCH & LOMB SAGLIKVE OPTIK ÜRÜNLERI TIC.A.S. |
| 3/27/2024 | 300190989000 | MUCOPROTEOSE * PHARMACEUTICAL RAW MATERIAL * IS NOT IN THE SCOPE OF ÜGD 2024/5 NOTIFICATION. (IT WILL BE USED IN HUMAN PHARMACEUTICALS INDUSTRY) | 720 | KILOGRAM | 66651 | N/A | KOÇAK FARMA İLAÇ VE KİMYA SANAYİ ANONİM ŞİRKETİ |